Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.
Journal: Nature medicine
Published: June 27, 2025
Genomic analysis reveals germline and somatic PDGFRB variants with clinical implications in familial infantile myofibromatosis.
Journal: Pediatric blood & cancer
Published: January 20, 2023
Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcoma.
Journal: The Journal of clinical investigation
Published: January 28, 2019
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence.
Journal: Nature medicine
Published: June 30, 2017
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.
Journal: Nature
Published: December 19, 2016
Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome.
Journal: Nature communications
Published: April 22, 2016
mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 10, 2016
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.
Journal: Nature
Published: November 25, 2015
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.
Journal: Critical reviews in oncogenesis
Published: September 10, 2015
Last Updated: 09/26/2026